Le Lézard
Classified in: Health
Subject: MAT

Stylus Research Reveals Five Trends in the "Legal Cannabis Era"


NEW YORK, June 19, 2018 /PRNewswire/ --

The legal cannabis era is here. As the 'green rush' to capitalize on it builds momentum in North America, innovation research and advisory company Stylus highlights five emerging trends shaping the future of cannabis culture and consumption.

     (Photo: https://mma.prnewswire.com/media/707082/Stylus_Cannabis.jpg )

1. Cannabis Versus Cocktails
Cannabis has the potential to match alcohol as the recreational product of choice in the US. Use among US college students is already climbing, while drinking is declining. It plays a similar role to alcohol, lending itself to party-goers, parents and others looking to unwind - even serving as a host gift in lieu of wine. It's especially appealing to those eager to avoid hangovers or alcohol's calorie count.

2. 'Canna-Curious' Hubs
Commercialized cannabis is maturing into an opportunity expected to be worth $57bn globally by 2027, according to Arcview Group. Catering to an influx of newly intrigued consumers, brands are demystifying cannabis via strategies such as subscription boxes, cannabis socials for product sampling, and even Tinder-like apps. The next stage in educating consumers and cultivating fans will be cannabis tourism. California-based Flow Kana is turning a defunct winery into an experience center that will offer educational tours of its cannabis farm, along with tastings.

3. Female Focus
A 'by and for' women's sector is booming in the industry. Women are among the fastest-growing cohorts of cannabis consumers, and increasingly prolific as cannabis entrepreneurs. As a result, products that skew towards feminine tastes - from menstrual-relief products to sleek pipes and jewelry that doubles as a sophisticated roach clip - are proliferating. Women are defining the future of cannabis.

4. Medical-Grade Marijuana
Cannabis hasn't yet been widely integrated into the mainstream medical community, but that will change. We'll see an upswing in education available for healthcare providers and patients, and an evolution of products geared to patient use - enabling users to more precisely control dosing, for instance. Legalization is bringing more biotech and other start-ups into the space, all likely to advance understanding of how cannabis can aid patients and help adapt it to clinical use.

5. New Pet Essential
As several key medical benefits of cannabidiol (CBD, the non-psychoactive compound of cannabis) - including relief from anxiety and joint pain - appear to help animals as much as humans, CBD-infused products for pets are booming. The potential here is enormous, given that Americans now spend nearly $70bn annually on their pets, and younger owners in particular are embracing alternative remedies to ensure optimal animal health.

About Stylus 
Stylus is a global innovation research and advisory company. We provide proprietary research and advice to more than 500 of the world's leading consumer brands, businesses and agencies. http://www.stylus.com

This is a sample of Stylus' latest research into the cannabis market. For additional commentary please contact:


Natasha Fish, PR Manager
[email protected]
+44 20 3892 7544

SOURCE Stylus.com


These press releases may also interest you

at 23:15
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: